Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors.
Sandra ClassenCordula PetersenKerstin BorgmannPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)
The combination of tested inhibitors of DNA damage and immune responses in preclinical models opens additional attractive options for the radiosensitization of tumors and represents a promising application for future therapeutic approaches.